The Board of Directors of Guizhou Yibai Pharmaceutical Co., Ltd. has authorized a buyback plan on November 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 CNY | +1.13% | -3.49% | -36.91% |
Apr. 18 | Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | YiBai Pharma to Repurchase Up to 40 Million Yuan Shares | MT |
1st Jan change | Capi. | |
---|---|---|
-36.91% | 393M | |
+40.73% | 739B | |
+31.80% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.88% | 240B | |
+9.36% | 210B | |
-5.03% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 600594 Stock
- News Guizhou Yibai Pharmaceutical Co., Ltd.
- Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.